US Patent Issued to National Health Research Institutes on June 30 for "Heterocyclic compounds as kinase inhibitors for therapeutic uses" (Taiwanese, American Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,584, issued on June 30, was assigned to National Health Research Institutes (Miaoli County, Taiwan).

"Heterocyclic compounds as kinase inhibitors for therapeutic uses" was invented by Hsing-Pang Hsieh (Miaoli County, Taiwan), Kun-Hung Lee (New Taipei City, Taiwan), Wen-Hsing Lin (Miaoli County, Taiwan) and Chuan Shih (Carmel, Ind.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Heterocyclic compounds of formula I shown below and pharmaceutical compositions containing one of such compounds: Also disclosed is a method of treating a condition modulated by the colony-stimulating factor-1 receptor with one of the heterocyclic compounds."

The patent was f...